
The Life Science Legal Strategy Summit 2026 is the premier gathering for the general counsel, chief legal officers, patent attorneys, regulatory lawyers and legal leaders designing, executing and future-proofing legal strategy across the life science sector. The summit unites the global life science legal ecosystem, from IP and patent strategy to regulatory exclusivities, competition law, M AND A, market access and the operational realities of a rapidly evolving legislative landscape. What you can expect: - 60+ speakers and 25+ sponsors, giving you direct access to the latest legal developments, strategic insights and expert perspectives- 2 specialised tracks: Track 1 covering IP and Regulatory Exclusivities, Track 2 covering Market Access, Deals and Competition, plus 15 interactive roundtable discussions across specialist topics- Industry-leading keynotes: past and confirmed speakers include James Horgan (Chief IP Counsel, MSD), Fleur Herrenschmidt (Chief Legal Officer, Norgine) and an exclusive keynote interview with the European Commission on life science antitrust enforcement- 450+ attendees from across the life science legal community, including senior legal teams from Regeneron, BioNTech, Novartis, Roche, Teva, AbbVie, Novo Nordisk, Bayer, Johnson and Johnson and Boehringer Ingelheim- 50% of attendees are senior in-house counsel, representing the legal functions that shape external counsel spend and drive strategic decision-making across the sector- 10+ hours of networking, including a Day 1 drinks reception, partner dinners, a General Counsel and CLO invitation-only briefing and dedicated networking breaks throughout both days Whether you are navigating the EU Pharma Package, managing antitrust exposure, building robust patent portfolios, structuring cross-border transactions or shaping your organisation's response to geopolitical and regulatory change, you will find tailored content, senior peers and dedicated networking opportunities to connect with the right people and sharpen your legal strategy. URLs:Tickets: https://go.evvnt.com/3725357-0?pid=5569 Brochure: https://go.evvnt.com/3725357-2?pid=5569 LinkedIn: https://go.evvnt.com/3725357-4?pid=5569 Date and Time: Tue, 13 Oct 2026 09:00 - Wed, 14 Oct 2026 18:00 Venue details: Frankfurt Marriott Hotel, 2 Hamburger Allee, Frankfurt am Main, Hessen, 60486, Germany Price:Free: EUR 0.00 Speakers: Alex Potlog, Senior Counsel, Global Legal Strategies and Policy, AbbVie, Cornelia Keller, VP and General Counsel, Merz Therapeutics, Filipe Pedro, Director of Intellectual Property, Bial, James Horgan, Chief IP Counsel, International Litigation and Policy, MSD, Laila Beynon, Director, Dispute Resolution, Regeneron, Simon Neill, Assistant General Counsel, Johnson and Johnson, Yvonne Madawela, Principal IP Counsel, Novartis, Zoe Kimberley, Area Counsel, Europe, AbbVie